Biomarkers, CDx & Precision Medicine Europe 2026NextGen Omics, Tech & Data Europe 2026
The business case for Basel

From more data to better decisions.

Two days that move your precision medicine decisions forward, with the people who make them.

13 to 14 October 2026Congress Centre Basel · Co-located850 people
Not sure which? Plan your visit
✓Two registrations, one venue. Once you're in, every session across both events is open to you.
The stakes

The market is growing fast. So is the cost of getting it wrong.

€100bn

Global biomarkers market by 2031, up from €60bn in 2026: 10.5% growth a year.1

€48.6bn

Cancer biomarkers by 2032, growing 11.6% a year.1

€15.8bn

Digital biomarkers by 2031, growing 19.1% a year.1

As spend grows, so does the cost of a wrong decision.

What the room is here to solve

334 challenges from registered delegates. Five shared problems.

We asked delegates what they're trying to solve. Each of the five answers has a session in Basel.2

01

Biomarker discovery & validation

SessionTranslating Biomarkers from Discovery to Clinical Use

02

Multi-omics & spatial integration

SessionTranslating Omics Data To Clinical Trial Decisions

03

AI & digital pathology

SessionDeploying foundation models, LLMs and agentic AI in pathology workflows

04

CDx & regulatory strategy

SessionIVDR Regulations & Their Impact

05

Liquid biopsy & trial stratification

SessionsBiomarker-driven trial design, and liquid biopsy for disease monitoring

Who's in the room

The whole precision medicine ecosystem, in one place.

850

people across delegates, solution providers, speakers and partners.2

400+delegates
230+organisations
36countries
Delegates by sector
Industry
59%
Academic
31%
Healthcare
8%
150

decision makers and key influencers, and 213 more who can introduce you to the decision maker.

Every side of the decision, in one room

Pharma, biotech and industry, academic research institutes, hospitals and healthcare, government and regulators.

Pharma
Pharma organisations registered for Basel 2026
Biotech
Biotech organisations registered for Basel 2026
Hospitals & healthcare
Hospitals & healthcare organisations registered for Basel 2026
Academic & research
Academic & research organisations registered for Basel 2026
Government & regulators
Government & regulators organisations registered for Basel 2026

Organisations registered for Basel 2026

Who can help you solve it
100+

solution provider companies and 10+ hours of pre-arranged 1:1 meetings, so you leave with conversations booked, not just business cards.

CROs & central labs

Labcorp, CellCarta, IQVIA Laboratories

Genomics & single cell

Illumina, 10x Genomics, Twist Bioscience

Spatial & pathology

Bio-Techne Spatial, Indica Labs, Hamamatsu

Diagnostics & assays

Roche Diagnostics, BD, Meso Scale Discovery

What you leave with

Two days in, a clearer plan out.

Better decisions, sooner

Pressure-test biomarker, CDx, data and AI choices with peers facing the same challenges.

The missing link

The partner, validation capability or regulatory expertise you need, across the table.

Less risk on what's coming

IVDR, diagnostic strategy and AI adoption, from teams already working through them.

A real benchmark

Pharma, biotech, academia and healthcare, in one room.

More from one trip

Two co-located events with shared access, in place of several specialist meetings.

One plan for the team

Bring colleagues, split across the sessions, and come back aligned.

Is Basel for you?

Plan your visit in a few minutes.

Answer a few quick questions to see how the event fits your work, build your personalised agenda, and get it sent to your inbox. Once you're in, every session across both events is open to you.

Come as a team

The biggest organisations aren't sending one person.

They're bringing whole teams. With shared access across both events, a team can cover far more ground in two days and come back aligned on one plan.

Biomarker and CDx colleagues register for Biomarkers, CDx & Precision Medicine Europe.

Omics, AI and data colleagues register for NextGen Omics, Tech & Data.

Once in, everyone can go everywhere. Split the sessions between you, then compare notes.

Need sign-off?

Make the case to your manager.

A short note you can copy, edit and send. Fill in the brackets and it's ready to go.

Subject: Request to attend [Biomarkers, CDx & Precision Medicine Europe 2026 / NextGen Omics, Tech & Data 2026], Basel, 13 to 14 October

Hi [Name],

I'd like to attend [event name] at Congress Centre Basel on 13 to 14 October. It is co-located with [other event name], and once registered I can attend sessions across both.

Why it's worth it for us:
• It goes straight at our work on [priority area], including [session title].
• 850 people from pharma, biotech, academia, healthcare and regulators, so I can benchmark our approach against teams facing the same challenges.
• 100+ solution providers and pre-arranged 1:1 meetings, so I can shortlist partners for [need] in two days rather than several separate meetings.
• I'll share a short summary and recommendations with the team by [date].

Registration is open now. Could you let me know by [date]?

Thanks,
[Your name]
Register your team

Basel, 13 to 14 October. Choose by focus.

Two co-located events, each with its own registration. Once you're in, every session across both is open to you.

13 to 14 October 2026 · Congress Centre Basel

Sources

1. MarketsandMarkets press releases, April to July 2026. Converted from USD at the ECB reference rate of 1.1204 (5 October 2026).

2. Oxford Global 2026 registration data as of 5 October 2026, rounded. 850 is expected total attendance across delegates, solution providers, speakers and partners.